China "must publish drug prices in advance"

23 April 2001

The Chinese government must publicize the prices of medicines andmedical products, and related policies, five to seven days before they take effect, according to an announcement by the State Development Planning Commission, reported by Xinhua.

This development is aimed at improving the timeliness and transparency of the government's pricing policies and enhancing public supervision over drug prices, it says, adding that the Commission has designated a number of pharmaceutical, medical and business journals to carry these announcements, plus two web sites, www.cei.gov.cn and www.cpic.govc.con.

In a communication to local governments, the Commission warns that all manufacturers and hospitals must adhere rigidly to the official policies and prices released through the designated media, or be penalized by the price supervision authorities.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight